129 related articles for article (PubMed ID: 10353335)
1. Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats.
Britton DR; Mikusa J; Lee CH; Jarvis MF; Williams M; Kowaluk EA
Neurosci Lett; 1999 May; 266(2):93-6. PubMed ID: 10353335
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice.
Kowaluk EA; Kohlhaas KL; Bannon A; Gunther K; Lynch JJ; Jarvis MF
Pharmacol Biochem Behav; 1999 May; 63(1):83-91. PubMed ID: 10340527
[TBL] [Abstract][Full Text] [Related]
3. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain.
Lynch JJ; Jarvis MF; Kowaluk EA
Eur J Pharmacol; 1999 Jan; 364(2-3):141-6. PubMed ID: 9932716
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats.
Jarvis MF; Mikusa J; Chu KL; Wismer CT; Honore P; Kowaluk EA; McGaraughty S
Pharmacol Biochem Behav; 2002 Oct; 73(3):573-81. PubMed ID: 12151032
[TBL] [Abstract][Full Text] [Related]
5. Adenosine kinase inhibition protects brain against transient focal ischemia in rats.
Jiang N; Kowaluk EA; Lee CH; Mazdiyasni H; Chopp M
Eur J Pharmacol; 1997 Feb; 320(2-3):131-7. PubMed ID: 9059845
[TBL] [Abstract][Full Text] [Related]
6. Regulation of extracellular adenosine levels in the striatum of aging rats.
Pazzagli M; Corsi C; Fratti S; Pedata F; Pepeu G
Brain Res; 1995 Jun; 684(1):103-6. PubMed ID: 7583197
[TBL] [Abstract][Full Text] [Related]
7. Effect of adenosine kinase, adenosine deaminase and transport inhibitors on striatal dopamine and stereotypy after methamphetamine administration.
GoĊembiowska K; Zylewska A
Neuropharmacology; 2000 Aug; 39(11):2124-32. PubMed ID: 10963755
[TBL] [Abstract][Full Text] [Related]
8. Effects of an adenosine kinase inhibitor and an adenosine deaminase inhibitor on accumulation of extracellular adenosine by equine articular chondrocytes.
Tesch AM; MacDonald MH; Kollias-Baker C; Benton HP
Am J Vet Res; 2002 Nov; 63(11):1512-9. PubMed ID: 12428660
[TBL] [Abstract][Full Text] [Related]
9. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices.
Golembiowska K; White TD; Sawynok J
Eur J Pharmacol; 1996 Jun; 307(2):157-62. PubMed ID: 8832217
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of adenosine kinase and adenosine uptake in guinea-pig CNS tissue by halogenated tubercidin analogues.
Davies LP; Cook AF
Life Sci; 1995 Mar; 56(17):PL345-9. PubMed ID: 8847946
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.
Hebb MO; White TD
Eur J Pharmacol; 1998 Mar; 344(2-3):121-5. PubMed ID: 9600645
[TBL] [Abstract][Full Text] [Related]
12. Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition.
Manthei SA; Reiling CM; Van Wylen DG
Cardiovasc Res; 1998 Jan; 37(1):171-8. PubMed ID: 9539871
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of excitatory amino acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine.
White TD
Eur J Pharmacol; 1996 May; 303(1-2):27-38. PubMed ID: 8804908
[TBL] [Abstract][Full Text] [Related]
14. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
[TBL] [Abstract][Full Text] [Related]
15. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy.
Wiesner JB; Ugarkar BG; Castellino AJ; Barankiewicz J; Dumas DP; Gruber HE; Foster AC; Erion MD
J Pharmacol Exp Ther; 1999 Jun; 289(3):1669-77. PubMed ID: 10336567
[TBL] [Abstract][Full Text] [Related]
16. Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply.
Smolenski RT; Raisky O; Slominska EM; Abunasra H; Kalsi KK; Jayakumar J; Suzuki K; Yacoub MH
Circulation; 2001 Sep; 104(12 Suppl 1):I246-52. PubMed ID: 11568064
[TBL] [Abstract][Full Text] [Related]
17. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures.
Lynch JJ; Alexander KM; Jarvis MF; Kowaluk EA
Neurosci Lett; 1998 Aug; 252(3):207-10. PubMed ID: 9739997
[TBL] [Abstract][Full Text] [Related]
19. Adenosine kinase inhibitors.
Kowaluk EA; Bhagwat SS; Jarvis MF
Curr Pharm Des; 1998 Oct; 4(5):403-16. PubMed ID: 10197052
[TBL] [Abstract][Full Text] [Related]
20. Formation and salvage of adenosine by macrovascular endothelial cells.
Deussen A; Bading B; Kelm M; Schrader J
Am J Physiol; 1993 Mar; 264(3 Pt 2):H692-700. PubMed ID: 8456972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
